Linagliptin Tablets 5mg

Product Details
Customization: Available
Package: 30tablets/Box
Composition: Linagliptin
Still deciding? Get samples of US$ 0.1/Piece
Request Sample
Manufacturer/Factory, Trading Company, Group Corporation
Gold Member Since 2018

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
to see all verified strength labels (7)
  • Linagliptin Tablets 5mg
  • Linagliptin Tablets 5mg
  • Linagliptin Tablets 5mg
  • Linagliptin Tablets 5mg
  • Linagliptin Tablets 5mg
Find Similar Products

Basic Info.

Model NO.
5mg
Transport Package
Free
Specification
5mg
Trademark
Sinolead
Origin
China

Product Description

Linagliptin Tablets 5mg
Product Dose Package
Linagliptin Tablets  5mg 30Tablets/box
Linagliptin Tablets 5mg
  • Linagliptin Tablets are a medication used in the management of type 2 diabetes mellitus. As a dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin works by enhancing the body's natural ability to lower blood sugar levels after meals.


Indications:
 

 

Linagliptin Tablets are indicated for the treatment of type 2 diabetes mellitus in adults, either as monotherapy or in combination with other antidiabetic medications, including metformin, sulfonylureas, or insulin. It is not indicated for the treatment of type 1 diabetes or diabetic ketoacidosis.



Administration:
 

Linagliptin Tablets are taken orally, once daily, with or without food. The dosage of linagliptin may vary depending on individual patient factors, including renal function and concomitant use of other antidiabetic medications. It is important to follow the prescribed dosage regimen and monitor blood sugar levels regularly to assess treatment efficacy.

Safety and Considerations:

While generally well-tolerated, Linagliptin Tablets may cause side effects such as:

  • Hypoglycemia: When used in combination with other antidiabetic medications, linagliptin may increase the risk of hypoglycemia, particularly in individuals at higher risk, such as those with renal impairment or elderly patients.
  • Upper respiratory tract infections: Common adverse reactions include nasopharyngitis, upper respiratory tract infections, or urinary tract infections, which are usually mild and transient.
  • Pancreatitis: Rarely, linagliptin may be associated with pancreatitis or pancreatic cancer, particularly in individuals with a history of pancreatitis or risk factors for pancreatic disease.
Linagliptin Tablets 5mgLinagliptin Tablets 5mgLinagliptin Tablets 5mgLinagliptin Tablets 5mg

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier